Your browser doesn't support javascript.
loading
Rituximab treatment did not aggravate ongoing progressive multifocal leukoencephalopathy in a patient with multiple sclerosis.
Asztely, F; Gilland, E; Wattjes, M P; Lycke, J.
Afiliação
  • Asztely F; Institute of Neuroscience and Physiology, Department of Clinical Neuroscience and Rehabilitation, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden. Electronic address: Fredrik.asztely@neuro.gu.se.
  • Gilland E; Institute of Neuroscience and Physiology, Department of Clinical Neuroscience and Rehabilitation, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.
  • Wattjes MP; Department of Radiology & Nuclear Medicine, VU University Medical Center, Amsterdam, The Netherlands.
  • Lycke J; Institute of Neuroscience and Physiology, Department of Clinical Neuroscience and Rehabilitation, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.
J Neurol Sci ; 353(1-2): 155-7, 2015.
Article em En | MEDLINE | ID: mdl-25908254
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucoencefalopatias / Rituximab / Fatores Imunológicos / Esclerose Múltipla Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucoencefalopatias / Rituximab / Fatores Imunológicos / Esclerose Múltipla Idioma: En Ano de publicação: 2015 Tipo de documento: Article